When Hasna was diagnosed with secondary breast cancer in 2016, she was told she may have only 18 months to live.

Thankfully, mother of three Hasna was referred to The Royal Marsden where she has taken part in several clinical trials. Targeted treatment on the PAveMenT trial – which is supported by The Royal Marsden Cancer Charity – has successfully reduced the volume of her cancer by 50% and her disease is now stable.

Hasna is so grateful to have the chance to see her children grow older and meet her grandchildren. It’s thanks to life-saving cancer research funded by the Charity that patients like Hasna can have more time with the people they love.